Abstract
High-mobility group box-1 (HMGB1) protein is a nuclear DNA-binding protein released from necrotic cells, inducing inflammatory responses and promoting tissue repair and angiogenesis. Diabetic human and mouse tissues contain lower levels of HMGB1 than their normoglycemic counterparts. Deficient angiogenesis after ischemia contributes to worse outcomes of peripheral arterial disease in patients with diabetes. To test the hypothesis that HMGB1 enhances ischemia-induced angiogenesis in diabetes, we administered HMGB1 protein in a mouse hind limb ischemia model using diabetic mice.
| Original language | English |
|---|---|
| Pages (from-to) | 1496-1505 |
| Number of pages | 10 |
| Journal | Diabetes |
| Volume | 59 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
Keywords
- Animals
- Blood Flow Velocity
- Diabetes Mellitus
- Experimental
- HMGB1 Protein
- Hindlimb
- Humans
- Inbred C57BL
- Ischemia
- Male
- Mice
- Muscle
- Neovascularization
- Pathologic
- Physiologic
- Skeletal
- Vascular Endothelial Growth Factor A
Fingerprint
Dive into the research topics of 'High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver